Polymeric microparticles (MPs) are recognized as very popular carriers to increase the
bioavailability and bio-distribution of both lipophilic and hydrophilic drugs. Among different …

Nanoparticles (NP) are attractive options for the therapeutic delivery of active
pharmaceutical drugs, proteins and nucleic acids into cells, tissues and organs. Research …

Conventional antibiotics used for treating tuberculosis (TB) suffer from drug resistance and
multiple complications. Here we propose a lesion–pathogen dual-targeting strategy for the …

Polysarcosine (pSar) is a polypeptoid based on the endogenous amino acid sarcosine (N-
methylated glycine), which has previously shown potent stealth properties. Here, lipid …

There are still some gaps in existing knowledge in the field of cancer nanotheranostics, eg.,
the efficiency of nanoparticle-loaded cells for targeted delivery. In the current study, gold …

Environmental exposure to nanoplastics is inevitable as the application of nanoplastics in
our daily life is more and more extensively. So, the adverse effects of nanoplastics on human …

Cancer theranostics that combines cancer diagnosis and therapy is a promising approach
for personalized cancer treatment. However, current theranostic strategies suffer from low …

With the rapid development of engineered nanomaterials for various applications, in vivo
toxicological studies for evaluating the potential hazardous effects of nanomaterials on …

The development of intelligent designs of new antibacterial modalities for diagnosing and
treating chronic multidrug-resistant bacterial infections is an urgent need, but achieving the …

Peptide drugs hold great potential for the treatment of infectious diseases due to their
unconventional mechanisms of action, biocompatibility, biodegradability and ease of …